Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.210
+0.020 (1.68%)
At close: Apr 2, 2025, 4:00 PM
1.232
+0.022 (1.80%)
After-hours: Apr 2, 2025, 7:55 PM EDT

BCLI Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
--17.19-24.28-24.46-31.81
Upgrade
Depreciation & Amortization
-0.270.290.260.22
Upgrade
Stock-Based Compensation
-1.491.681.372.56
Upgrade
Change in Accounts Receivable
--0.481.070.341.49
Upgrade
Change in Accounts Payable
--1.272.52-1.72-9.26
Upgrade
Change in Other Net Operating Assets
--3.28-0.6-2.051.61
Upgrade
Operating Cash Flow
--20.46-19.32-26.27-35.19
Upgrade
Capital Expenditures
--0.02-0.03-0.33-0.38
Upgrade
Investment in Securities
-2.211.030.65-4.07
Upgrade
Investing Cash Flow
-2.1910.32-4.45
Upgrade
Issuance of Common Stock
-18.980.246.9777.05
Upgrade
Repurchase of Common Stock
-----0.12
Upgrade
Financing Cash Flow
-18.980.246.9776.94
Upgrade
Net Cash Flow
-0.71-18.08-18.9737.29
Upgrade
Free Cash Flow
--20.48-19.35-26.6-35.57
Upgrade
Free Cash Flow Per Share
--7.13-7.95-11.03-17.88
Upgrade
Levered Free Cash Flow
--12.49-10-17.64-23.81
Upgrade
Unlevered Free Cash Flow
--12.31-10-17.64-23.73
Upgrade
Change in Net Working Capital
-1.630.65-3.583.66.33
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q